BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24724398)

  • 21. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria).
    Rahmouni A; Luciani A; Itti E
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S102-6. PubMed ID: 16361124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The progress of laboratory medicine and diagnostic procedures in lymphoma and its future prospects].
    Okamoto M
    Nihon Rinsho; 2014 Mar; 72(3):391-8. PubMed ID: 24724393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic infrared imaging of newly diagnosed malignant lymphoma compared with Gallium-67 and Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography.
    Janicek MJ; Demetri G; Janicek MR; Shaffer K; Fauci MA
    Technol Cancer Res Treat; 2003 Dec; 2(6):571-8. PubMed ID: 14640768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET and PET/CT in malignant lymphoma.
    Reske SN
    Recent Results Cancer Res; 2008; 170():93-107. PubMed ID: 18019620
    [No Abstract]   [Full Text] [Related]  

  • 27. PET/CT in malignant lymphoma: basic information, clinical application, and proposal.
    Tateishi U
    Int J Hematol; 2013 Oct; 98(4):398-405. PubMed ID: 24065513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET/CT in evaluation and prognostication of primary prostate lymphoma.
    Hodgson R; Huang YT; Steinke K; Ravi Kumar AS
    Clin Nucl Med; 2010 Jun; 35(6):418-20. PubMed ID: 20479589
    [No Abstract]   [Full Text] [Related]  

  • 29. Reticuloendothelium malignancy: current role of imaging.
    Sebastian S; Lucey BC
    Cancer Treat Res; 2008; 143():455-68. PubMed ID: 18619228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoma imaging: nuclear medicine.
    Kostakoglu L; Goldsmith SJ
    Cancer Treat Res; 2006; 131():363-412. PubMed ID: 16704177
    [No Abstract]   [Full Text] [Related]  

  • 31. [New trends and novel possibilities in the diagnosis of lymphomas].
    Illés Á; Simon Z
    Magy Onkol; 2015 Mar; 59(1):73-8. PubMed ID: 25763917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?
    Adams HJA; Kwee TC
    Lancet Oncol; 2019 Jan; 20(1):e4. PubMed ID: 30614476
    [No Abstract]   [Full Text] [Related]  

  • 33. Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply.
    Trotman J; Barrington SF; Meignan M;
    Lancet Oncol; 2019 Jan; 20(1):e5. PubMed ID: 30614478
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary lymphoma of the liver: a diagnostic surprise.
    Amaral Ferreira L; Costa JF; Donato P; Caseiro-Alves F
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635322
    [No Abstract]   [Full Text] [Related]  

  • 35. [A computer aided diagnosis system for malignant tumors using FDG-PET/CT images].
    Hontani H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 Dec; 63(12):1460-3. PubMed ID: 18311011
    [No Abstract]   [Full Text] [Related]  

  • 36. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings.
    Lee WK; Lau EW; Duddalwar VA; Stanley AJ; Ho YY
    AJR Am J Roentgenol; 2008 Jul; 191(1):198-206. PubMed ID: 18562746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance imaging for lymphoma: pros and cons.
    Lynch RC; Zelenetz AD; Armitage JO; Carson KR
    Am Soc Clin Oncol Educ Book; 2014; ():e388-95. PubMed ID: 24857129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic Management of Exophthalmos].
    Klingenstein A; Hintschich C
    Klin Monbl Augenheilkd; 2017 Jan; 234(1):53-58. PubMed ID: 28135745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response criteria for malignant lymphoma.
    Maffione AM; Paolini R; Rodella E; Ambrosio C; Rampin L; Lisato LC; Ballotta M; Pavanato G; Rubello D
    Nucl Med Commun; 2015 Apr; 36(4):398-405. PubMed ID: 25603273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABDOMINAL LYMPHOMA: IMAGING WORK UP CHALLENGES AND RECOMMENDATIONS IN RESOURCE LIMITED SETUP.
    Kebede AA; Bekele F; Assefa G
    Ethiop Med J; 2014 Oct; 52(4):197-206. PubMed ID: 26410993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.